2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl) -N,N-diMethylacetaMide
97%
- Product Code: 191890
CAS:
178554-19-3
| Molecular Weight: | 485.5807 g./mol | Molecular Formula: | C₂₇H₃₁N₇O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00947954 | |
| Melting Point: | Boiling Point: | 705.9±70.0 °C(Predicted) | |
| Density: | 1.24±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C |
Product Description:
Used primarily in the pharmaceutical industry as an intermediate in the synthesis of angiotensin II receptor antagonists, particularly in the production of antihypertensive drugs. It plays a key role in developing medications that manage high blood pressure and related cardiovascular conditions by blocking the action of angiotensin II, a substance that narrows blood vessels. Due to its functional groups, including the tetrazole ring and pyrimidine core, it enhances binding affinity to biological targets, improving drug efficacy. Its structure supports metabolic stability and bioavailability in final drug formulations.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 G | 10-20 days | ฿6,400.00 |
+
-
|
| 0.250 G | 10-20 days | ฿10,880.00 |
+
-
|
| 1.000 G | 10-20 days | ฿32,000.00 |
+
-
|
2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl) -N,N-diMethylacetaMide
Used primarily in the pharmaceutical industry as an intermediate in the synthesis of angiotensin II receptor antagonists, particularly in the production of antihypertensive drugs. It plays a key role in developing medications that manage high blood pressure and related cardiovascular conditions by blocking the action of angiotensin II, a substance that narrows blood vessels. Due to its functional groups, including the tetrazole ring and pyrimidine core, it enhances binding affinity to biological targets, improving drug efficacy. Its structure supports metabolic stability and bioavailability in final drug formulations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :